Novo asks court to block Lilly ads; Merck strikes HIV PrEP deal

GLP-1Negative

AI Analysis

Summary

Novo Nordisk sought a court order to block Lilly's GLP-1 advertisements, while Merck announced an HIV PrEP partnership deal. The article also references news from AbbVie, Genmab, Johnson & Johnson, and Mannkind.

Outcome Details

Novo Nordisk filed court action to block Lilly GLP-1 advertisements

Importance:5/10

Sentiment:

-0.50

legallitigationGLP-1advertisingM&AHIVPrEP

Related Companies

$NVO $LLY $MRK $ABBV $GMAB $JNJ

Read the original article

Published by Endpoints News on July 24, 2026 2:08 PM

Read Original